Detalhe da pesquisa
1.
Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.
Eur J Haematol
; 110(6): 659-668, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813736
2.
Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
Biol Blood Marrow Transplant
; 25(9): 1825-1831, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152794
3.
Allogeneic stem cell transplant in relapsed/ refractory Hodgkin lymphoma: A 21 years' experience.
Porto Biomed J
; 7(5): e173, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37213920
4.
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial.
Lancet Haematol
; 9(1): e14-e25, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34971577
5.
PTX3 Polymorphisms Influence Cytomegalovirus Reactivation After Stem-Cell Transplantation.
Front Immunol
; 10: 88, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30766534
6.
Acute kidney injury after allogeneic hematopoietic stem cell transplantation Predictors and survival impact: A single center retrospective study / Lesión renal aguda después de trasplante de células madre hematopoyéticas alogénicas, factores predictivos e impacto en la supervivencia: un estudio retrospectivo en un solo centro
Nefrología (Madrid)
; 42(6): 656-663, nov.-dic. 2022. tab, graf
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-212594
7.
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.
Leukemia
; 35(12): 3585-3588, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750508